Advancing Glucose Data Collection
Technology advancements in continuous glucose monitoring (CGM) used for research and treatment of both Type 1 and Type 2 Diabetes are rapidly increasing. IQVIA Connected Devices is modernizing clinical development with industry-leading innovation to drive faster and increased data collection, with a better patient-centric experience, by collecting a more complete and dynamic view of the daily measures of glucose levels and variability than traditional measures of glucose control by self-monitored blood glucose (SMBG) and Hemoglobin A1c (HbA1c).
Our eSource technology and portfolio of digital and connected CGM solutions work together to mitigate risk and consolidate, verify and analyze continuous bidirectional data flow, all in a centralized view within our Connected Devices Digital Platform.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.